{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:26:49Z","timestamp":1774628809239,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"vor","delay-in-days":177,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hydroxyurea (HU) is a ribonucleotide diphosphate reductase inhibitor that interferes with the S phase of cell replication and inhibits DNA synthesis, with limited or no effect on RNA or protein synthesis. The cutaneous side effects of hydroxyurea treatment are diverse and frequent. Squamous cell carcinoma is one of the most challenging side-effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>The authors report the case of a healthy 59-year-old woman on long-term therapy with Hydroxyurea 500 mg daily for essential thrombocytosis, presented with a painless slow-growing lesion of the jaw that had persisted and increased in size for six months, the appearance of the lesion is correlated to the administration of the hydroxyurea treatment. Clinical examination revealed a large nodular lesion 4 \u00d7 4 cm with irregular borders of the right cheek, infiltrated into underlying tissue, the lesion extending to the free border of the right lower eyelid without sensory disturbances or diplopia. The surgery was indicated. The surgical procedure had the aim of the restoration of the anatomic landmarks after a large excision of the tumor and reconstruction of full-thickness eyelid defect with a local flap under general anesthesia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Maxillofacial surgeons must be aware of the side effects of hydroxyurea including facial cancer, ulceration, etc. Rigorous follow-up of patients on hydroxyurea is required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2021.106160","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T12:11:29Z","timestamp":1625055089000},"page":"106160","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Squamous cell carcinoma during long term hydroxyurea treatment"],"prefix":"10.1097","volume":"85","author":[{"given":"Ouassime","family":"Kerdoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachid","family":"Aloua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amine","family":"Kaouani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousmane","family":"Belem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fai\u00e7al","family":"Slimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20260114","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3181\/00379727-119-30209","article-title":"Activity of congeners of hydroxyurea against advanced leukemia L1210","volume":"119","author":"Adamson","year":"1965","journal-title":"Proc. Soc. Exp. Biol. Med"},{"key":"R2-12-20260114","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1021\/jm00338a026","article-title":"A new type of potential antitumor agent","volume":"6","author":"Stearns","year":"1963","journal-title":"J. Med. Chem"},{"key":"R3-12-20260114","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/jb.94.4.1025-1033.1967","article-title":"Studies with hydroxyurea. VII. Hydroxyurea and the synthesis of functional proteins","volume":"94","author":"Rosenkranz","year":"1967","journal-title":"J. Bacteriol"},{"key":"R4-12-20260114","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1182\/blood-2014-08-435768","article-title":"Update on the use of hydroxyurea therapy in sickle cell disease","volume":"124","author":"Wong","year":"2014","journal-title":"Blood"},{"key":"R5-12-20260114","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4065\/73.10.961","article-title":"Multiple skin cancers associated with hydroxyurea therapy","volume":"73","author":"Best","year":"1998","journal-title":"Mayo Clin. Proc"},{"key":"R6-12-20260114","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2230.2001.00782.x","article-title":"Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia","volume":"26","author":"Vassallo","year":"2001","journal-title":"Clin. Exp. Dermatol"},{"key":"R7-12-20260114","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3889\/oamjms.2018.320","article-title":"Hydroxyurea associated cutaneous lesions: a case report","volume":"6","author":"Simeonovski","year":"2018","journal-title":"Open Access Maced. J. Med. Sci"},{"key":"R8-12-20260114","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.12998\/wjcc.v7.i23.4091","article-title":"Hydroxyurea-induced cutaneous squamous cell carcinoma: a case report","volume":"7","author":"Xu","year":"2019","journal-title":"World J. Clin. Cases"},{"key":"R10-12-20260114","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0190-9622(08)81758-6","article-title":"Multiple skin tumors on light-exposed areas during long-term treatment with hydroxyurea","volume":"28","author":"Papi","year":"1993","journal-title":"J. Am. Acad. Dermatol"},{"key":"R12-12-20260114","first-page":"919","article-title":"Carcinomes cutan\u00e9s et buccaux multiples apr\u00e8s traitement par l\u2019hydroxyur\u00e9e","volume":"128","author":"Est\u00e8ve","year":"2001","journal-title":"Ann. Dermatol. Venereol"},{"key":"R13-12-20260114","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1349-7006.2001.tb02136.x","article-title":"Hydroxyurea induces site-specific DNA damage via formation of hydrogen peroxide and nitric oxide","volume":"92","author":"Sakano","year":"2001","journal-title":"Jpn. J. Cancer Res"},{"key":"R14-12-20260114","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00105-008-1673-1","article-title":"Multiple kutane Neoplasien nach Therapie mit Hydroxyurea","volume":"60","author":"Wiechert","year":"2009","journal-title":"Hautarzt"},{"key":"R15-12-20260114","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00105-009-1844-8","article-title":"Kutane Nebenwirkungen einer Hydroxyurea-Therapie bei Polycythaemia vera","volume":"60","author":"Hoff","year":"2009","journal-title":"Hautarzt"},{"key":"R16-12-20260114","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaad.2003.11.059","article-title":"Hydroxyurea-associated squamous dysplasia","volume":"51","author":"Sanchez-Palacios","year":"2004","journal-title":"J. Am. Acad. Dermatol"},{"key":"R17-12-20260114","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2230.2004.01586.x","article-title":"Oral squamous cell carcinoma during long-term treatment with hydroxyurea","volume":"29","author":"De Benedittis","year":"2004","journal-title":"Clin. Exp. Dermatol"},{"key":"R18-12-20260114","first-page":"274","article-title":"Multiple actinic keratosis and skin tumors secondary to hydroxyurea treatment","volume":"196","author":"Salmon-Ehr","year":"1998","journal-title":"Dermatology"},{"key":"R19-12-20260114","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.amsu.2021.01.025","article-title":"The deltopectoral flap in full-thickness cheek defect: a case report","volume":"62","author":"Kerdoud","year":"2021","journal-title":"Ann. Med. Surg"},{"key":"R20-12-20260114","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/ajd.13436","article-title":"Hydroxyurea-induced squamous cell carcinoma","volume":"62","author":"Brown","year":"2021","journal-title":"Aust. J. Dermatol"},{"key":"R21-12-20260114","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2257.2003.00534.x","article-title":"Metastatic squamous cell carcinoma of the skin in chronic myeloid leukaemia: complication of hydroxyurea therapy","volume":"25","author":"Pamuk","year":"2003","journal-title":"Clin. Lab. Haematol"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261221006623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261221006623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2021.106160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:24:30Z","timestamp":1768397070000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2021.106160"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":19,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2021.106160","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}